<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> <z:hpo ids='HP_0000488'>retinopathy</z:hpo> is a rare and poorly defined clinical entity in which the proper diagnosis has important ocular and systemic implications </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical course of five patients with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> <z:hpo ids='HP_0000488'>retinopathy</z:hpo> is described and the role of such antibodies in idiopathic <z:chebi fb="46" ids="15035">retinal</z:chebi> venous occlusive disease is investigated </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Five case reports are presented highlighting the presentation, course, therapy, associations and outcomes of patients with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, twenty additional patients presenting with idiopathic <z:chebi fb="46" ids="15035">retinal</z:chebi> venous occlusive disease were tested for the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> five patients with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> <z:hpo ids='HP_0000488'>retinopathy</z:hpo> had diffuse <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> five patients presented with associated rheumatologic disease, including three with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease </plain></SENT>
<SENT sid="6" pm="."><plain>Antibodies to antiphospholipid were not detected in any of the twenty patients with idiopathic <z:chebi fb="46" ids="15035">retinal</z:chebi> venous occlusive disease </plain></SENT>
<SENT sid="7" pm="."><plain>Prompt panretinal photocoagulation together with varying regimens of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, immunosuppressives, or <z:chebi fb="8" ids="10033">warfarin</z:chebi> was partially successful in stabilizing the ocular and <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The diagnosis of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> <z:hpo ids='HP_0000488'>retinopathy</z:hpo> should be suspected in patients with diffuse <z:chebi fb="46" ids="15035">retinal</z:chebi> vaso-occlusion, particularly when characterized by involvement of both arteries and veins, neovascularization at presentation, and symptoms of symptoms of systemic rheumatologic disease </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> do not appear to play an important role in idiopathic <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusions </plain></SENT>
</text></document>